Selected Tag: Zydus Lifesciences
Selected Tag: Zydus Lifesciences

Most Indian Pharma Exports May Escape US Tariff, But Uncertainty Clouds Branded Generics 

US 100% tariff plan sparks confusion: if branded generics are treated as patented drugs, India is safe; if as branded imports, then some pharma exports face trouble.

Ajay Srivastava

September 26, 2025 at 7:56 AM IST

Article related image

Istock.com/moussa81

Zydus Lifesciences Inks Pact With Synthon For US Launch of Generic Zeposia

BasisPoint Insight

September 5, 2025 at 6:46 AM IST

Zydus Subsidiary Reports Positive Trial Results for Liver Drug Saroglitazar

BasisPoint Insight

September 2, 2025 at 10:28 AM IST

Zydus Lifesciences Gets 4 US FDA Observations for Baddi Plant

BasisPoint Insight

August 18, 2025 at 6:52 AM IST

Zydus Lifesciences Invests ₹38.7 Million In Torrent Urja 25

BasisPoint Insight

June 30, 2025 at 9:10 AM IST

Zydus Gets 2 US FDA Observations For Ahmedabad Oncology Site

BasisPoint Insight

June 19, 2025 at 8:52 AM IST

Zydus Healthcare Appoints Swati Dalal As MD For Five-Year Term

BasisPoint Insight

June 17, 2025 at 9:10 AM IST

Zydus Gets USFDA Nod For Ankleshwar API Unit

BasisPoint Insight

June 12, 2025 at 10:11 AM IST

US FDA Ends Zydus Lifesciences’ Dabhasa Plant inspection With VAI tag

BasisPoint Insight

June 11, 2025 at 7:23 AM IST

Zydus To Acquire Two US Biologics Units For $75 Million, Signs Multiple Agreements

BasisPoint Insight

June 4, 2025 at 7:57 AM IST

Zydus Lifesciences Gets Tentative USFDA Nod For Rifaximin Tablets

BasisPoint Insight

June 3, 2025 at 7:45 AM IST

Delhi HC Restrains Zydus Green Energy From Using ‘Zydus’ Trademark

BasisPoint Insight

June 2, 2025 at 10:33 AM IST

Zydus Lifesciences' ALS Drug Usnoflast Gets US FDA Fast Track Status

BasisPoint Insight

May 30, 2025 at 9:18 AM IST

Zydus Gets USFDA Nod For Generic Absorica Acne Treatment

BasisPoint Insight

May 26, 2025 at 11:46 AM IST

Zydus Lifesciences Posts Slight Profit Dip Despite Strong Sales Growth

BasisPoint Insight

May 22, 2025 at 10:45 AM IST

Zydus Gets Clean Chit From US FDA For Ambernath API Plant

BasisPoint Insight

May 15, 2025 at 9:45 AM IST

Zydus Lifesciences Gets USFDA Nod For Multiple Sclerosis Drug

BasisPoint Insight

May 12, 2025 at 9:19 AM IST

Zydus Gets USFDA Nod To Launch Niacin Extended-Release Tablets

BasisPoint Insight

May 2, 2025 at 2:32 AM IST

Zydus Lifesciences Gets Six US FDA Observations For Dabhasa Unit

BasisPoint Insight

April 29, 2025 at 1:40 AM IST

Zydus Life To Raise Stake In Amplitude Surgical To Over 90%

BasisPoint Insight

April 18, 2025 at 10:04 AM IST

Zydus VC Arm Invests In Canada’s Feldan Therapeutics

BasisPoint Insight

April 18, 2025 at 10:02 AM IST

The Bureau

Venkat Chalasani on AMFI, Ethics, and Financial Literacy
Jallikattu: Tamil Nadu’s Ancient Bull-Taming Tradition
Image